Related Experiment Video
Updated: Jul 20, 2026

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions
Published on: August 12, 2010
Toxoplasma gondii impairs CX3CL1/fractalkine shedding from mouse cortical neurons, leading to microglia activation
Leonardo Leal de Castro1,2,3, Barbara Gomes da Rosa1, Maria Carolina Peixoto-Rodrigues1
1Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Abstract:
Toxoplasmosis is caused by infection with Toxoplasma gondii and is one of the most prevalent food-borne parasitic disease worldwide. T. gondii disseminates through the host organism and forms a latency-specific structure called bradyzoite cysts, found primarily in muscle and neuronal cells. In mice, Toxoplasma leads to sustained brain microvascular abnormalities, including capillary rarefaction, microglial activation, and blood-brain barrier (BBB) breakdown, resulting in synaptic and neuronal loss, behavioral and cognitive damages. We hypothesized that cyst-bearing neurons could signal distinct classes of molecules that would orchestrate neurovascular and neuroinflammatory processes. Primary mouse cortical neurons were infected with T. gondii (ME49 strain) tachyzoites, which, 7 days post infection, generated cysts. We determined angiogenic-regulating factors from the neuronal conditioned media (nCM) using a proteome array and found nine molecules, belonging to four main functional clusters: (i) angiogenic signaling (VEGFA); (ii) endothelial-regulating growth factors (IGFBP-2, -3, -9 and PDGF-AA), (iii) chemoattractants (CCL-2, CCL-3, and CXCL12), and (iv) fractalkine signaling (CX3CL1). The main targets were validated in neuronal culture samples and in brain cortices by ELISA, RT-qPCR, or immunoblotting. CX3CL1 secretion was reduced in infected cultures and accumulated on neuronal surface. In vivo, the CX3CL1 receptor (CX3CR1) was upregulated, whereas the CX3CL1 soluble fraction was decreased. Recombinant CX3CL1 decreased arginase-1 and increased iNOS expression in nCM-treated microglial cells, indicating that CX3CL1 polarizes microglia to a pro-resolutive state. Our data suggest that CX3CL1 plays a key role in regulating neuroinflammatory signaling in acquired Toxoplasmosis, highlighting its potential to prevent the neurocognitive damage observed in infected individuals.
Importance:
Toxoplasma gondii is a widespread parasite that forms latent cysts in neurons during chronic brain infection. How these infected neurons contribute to long-term brain damage is not well understood. In this study, we used a neuron-specific culture system and a mouse model to show that T. gondii infection alters the release of key signaling molecules by neurons. We found that infected neurons reduce secretion of fractalkine, a molecule that normally helps keep brain immune cells (microglia) in a resting state. At the same time, infected neurons showed increased expression of inflammatory and vascular-related genes, but not always matching increases in protein levels, pointing to complex regulation. These changes may contribute to blood-brain barrier dysfunction and persistent inflammation seen in chronic infection. Our findings highlight the role of neuron-derived signals in driving T. gondii-induced brain pathology and identify fractalkine as a potential target to reduce inflammation.
Insights
Toxoplasma gondii infection alters neuron signaling, reducing fractalkine (CX3CL1) and potentially worsening brain inflammation and damage. Restoring CX3CL1 may offer therapeutic benefits for neurocognitive deficits.
Area of Science:
- Neuroscience
- Immunology
- Parasitology
Background:
- Toxoplasmosis, caused by *Toxoplasma gondii*, is a prevalent food-borne illness.
- Chronic *T. gondii* infection leads to brain microvascular abnormalities, neuroinflammation, and cognitive deficits.
- The role of infected neurons in orchestrating these pathological processes remains unclear.
Purpose of the Study:
- To investigate how *T. gondii*-infected neurons signal to influence neurovascular and neuroinflammatory responses.
- To identify key molecules released by infected neurons that contribute to brain pathology.
- To explore the therapeutic potential of targeting neuron-derived signaling molecules.
Main Methods:
- Primary mouse cortical neurons were infected with *T. gondii* (ME49 strain).
- Proteome arrays were used to identify signaling molecules in conditioned neuronal media.
- ELISA, RT-qPCR, and immunoblotting validated target molecules in vitro and in vivo.
- Microglial responses to recombinant fractalkine (CX3CL1) were assessed.
Main Results:
- Infected neurons exhibited altered secretion of nine key molecules, including VEGFA, IGFBPs, PDGF-AA, CCLs, and CX3CL1.
- CX3CL1 secretion was reduced in infected neurons, while its receptor (CX3CR1) was upregulated in vivo.
- Recombinant CX3CL1 modulated microglial activation markers (arginase-1 and iNOS), suggesting a shift towards a pro-resolutive state.
- Gene expression changes in infected neurons did not always correlate with protein level alterations.
Conclusions:
- *T. gondii*-infected neurons release specific signaling molecules that drive neuroinflammation and vascular changes.
- Reduced CX3CL1 secretion by infected neurons may contribute to sustained neuroinflammation and cognitive impairment.
- CX3CL1 signaling is a critical regulator of neuroinflammatory responses in toxoplasmosis.
- Targeting CX3CL1 presents a potential therapeutic strategy to mitigate neurocognitive damage in toxoplasmosis.
More Related Videos
06:333-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii
Published on: December 9, 2014
11:21Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015